Non-technical summary
The global fight against COVID-19 is plagued by asymptomatic transmission and false negatives. Group testing is increasingly recognized as necessary to fight this epidemic. I examine the gains from considering heterogeneous interpersonal interactions (homophily), which induce potential contamination, when designing testing pools. Homophily can be identified ex ante at a scale commensurate with pool size, so that the risk of contamination is higher within a well-designed pool than with an outsider. This makes it possible to overcome the usual information-theoretic limits of group testing which rely on an implicit homogeneity assumption. More importantly, group testing with homophily detects asymptomatic carriers that would be missed even by exhaustive individual testing because of false negatives. Such a strategy should be implemented at least at a weekly frequency to fit the time profile of test positivity. It can be used either to avoid unnecessary lockdowns or to make lockdowns more efficient.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The study has not benefited from any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study does not include any experiment: no IRB nor ethical committee approval was needed, no patient/participant consent was needed, and no institutional forms needed to be archived
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
All relevant ethical guidelines have been followed
This study does not include any experiment: no IRB nor ethical committee approval was needed, no patient/participant consent was needed, and no institutional forms needed to be archived
The study has not benefited from any funding
The author has no conflict of interest
1 I thank Marc Fleurbaey and seminar participants at Paris School of Economics for very useful comments and suggestions. The opinions expressed here are those of the author only. The usual disclaimer applies
Data Availability
No data: mathematical analysis